BioSpectrum Asia recently completed a survey of close to 500 bioscience companies listed on different stock exchanges in both the Asia Pacific region (APAC) and in American stock exchanges, with total revenue of $139 billion (year end 2011) and market capitalization of $200 billion.
The survey says of the top 20 companies in the region, comprising mostly of pharmaceutical, biotechnology and medical technology companies and focusing on R&D, manufacturing and marketing of life sciences products, all 20 have recorded a market capitalization of $100 billion and the top 50 companies have market capitalization of $138 billion.
Three nations, India, Australia and China, had companies accounting for over 80 percent of the total market capitalization. Indian companies have the highest share which is no surprise as India is the world’s largest manufacturer of vaccines. The growth of India vaccine makers arises from their ability to develop and produce high-quality vaccines with low manufacturing costs, which have been primarily marketed in the developing world.
Recognizing India as a model for the global vaccine market as well as the tremendous growth in the both the Indian economy and its healthcare sector, now is a critical time to capitalize on the biotech opportunities available within India.
The third annual BIO India International Conference will be held September 12-13 at the Grand Hyatt in Mumbai, India. BIO India will feature high-level keynote speakers, education panels on the latest trends, networking opportunities, company presentations and partnering meeting opportunities through the BIO One-on-One Partnering™ system.
BIO’s partner in India is the Association of Biotechnology Led Enterprises (ABLE), which represents Indian and Asian biotechnology and pharmaceutical companies, as well as leading investment banks and venture capital firms. ABLE is to co-host this dynamic event for a third consecutive year.
For program, partnering and registration information on the BIO India International Conference, please visit here.